Billede af showet Kicking Gout in the Acid

Kicking Gout in the Acid

Podcast af Gout Education Society

engelsk

Videnskab & teknologi

Derefter 99 kr. / måned. Opsig når som helst.

  • 20 lydbogstimer pr. måned
  • Podcasts kun på Podimo
  • Gratis podcasts

Læs mere Kicking Gout in the Acid

Learn more about gout causes, symptoms, and treatment with Gout Education Society Chairman, Larry Edwards, MD, MACR, MACP, alongside other gout experts from across the world.

Alle episoder

10 episoder

episode Gout Rx: Past, Present, and Future cover

Gout Rx: Past, Present, and Future

Welcome to the second season finale Kicking Gout in the Acid. This season dove into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. The season finale of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Brian Mandell, rheumatologist from the Cleveland Clinic, and member of the Gout Education Society’s Board of Directors. In this episode, Dr. Edwards and Dr. Mandell will look back at the history of gout treatment, discuss the current state of affairs for medications in development, and look towards the future of disease management.  Key Takeaways: Early treatments focused on symptom relief rather than the underlying disease, delaying recognition of gout as a condition driven by urate deposition that requires targeted, long‑term management. Medications like probenecid and later allopurinol reframed gout as a chronic condition that can be controlled by consistently lowering and maintaining serum urate to a defined target. This strategy opened the door to new options like febuxostat, uricosurics, and uricase-based therapies that allow for more individualized care. The future of gout treatment is bright with options as many are in the clinical pipeline. To Dr. Edwards and Dr. Mandell, an option that not only lowers urate more effectively but also directly targets inflammation pathways could be an interesting area of future research. Gout is treatable and curable when managed correctly. Successful outcomes depend on a team-based approach involving informed patients, appropriate medication use, adherence to treat‑to‑target principles, and consistent follow‑up. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi.

4. maj 2026 - 24 min
episode Heart Health and Gout: Connecting the Dots cover

Heart Health and Gout: Connecting the Dots

Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Ken Saag, rheumatologist, professor, and director in UAB Medicine’s Division of Clinical Immunology and Rheumatology, member of the Gout Education Society’s Board of Directors. The two dive into the link between gout and cardiovascular disease, why flares may increase risk for CV events, and clinical recommendations that medical professionals should consider when someone faces both conditions. Key Takeaways: The link between gout and cardiovascular disease remains complex and often misunderstood. While biological plausibility exists, human data are mixed, creating uncertainty about how strongly uric acid contributes to long‑term heart outcomes. Gout flares themselves may carry cardiovascular risk. Acute flares are highly inflammatory, and emerging evidence suggests they may directly increase the likelihood of cardiovascular events which underscores the need for proactive flare prevention. Those with both gout and heart disease benefit from aggressive management based on the treat-to-target approach. Lowering serum urate, preventing flares, and maintaining overall cardiovascular stability remain key goals for improving outcomes for those facing both conditions. Lifestyle changes can be helpful in those with gout, but medication is essential to treat a majority of cases. Although weight loss and dietary changes provide modest improvements, they rarely reduce uric acid enough on their own. Sustainable management still depends on appropriately titrated urate‑lowering therapy. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi.

31. mar. 2026 - 27 min
episode The Challenge of Coordinated Gout Treatment cover

The Challenge of Coordinated Gout Treatment

Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Tuhina Neogi, Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine (BUSM), Chief of Rheumatology at Boston Medical Center, and member of the Gout Education Society’s Board of Directors. The two explore the common areas where gout patients are seen, common pitfalls that occur throughout the process of multidisciplinary management, and the importance of promoting the ACR gout guidelines among professionals. Key Takeaways: Gout is still not viewed as an important rheumatic disease by many providers, leading to under-treatment and missed opportunities for proper management. Under-treated gout, or treatment only focused on symptoms, can lead to uncontrolled hyperuricemia, worsening tophi, and patients losing trust in their physicians. There is growing involvement in specialists treating gout, however, inconsistent knowledge on managing the disease can lead to unnecessary medication holds, recurrent flares, and patient confusion. Many myths still hold the attention of those with the disease and medical professionals alike. Notably, the disease shouldn’t be seen as episodic, rather it should be seen as chronic, requiring lifelong therapy that aligns with the treat-to-target approach. Educated patients are advocates for themselves. This can be particularly helpful when their care team has differing opinions. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi.

23. feb. 2026 - 25 min
episode Gout and Genetics: What Your Background Might Mean cover

Gout and Genetics: What Your Background Might Mean

Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Robert Keenan, Rheumatologist, Chief Medical Officer at Arthrosi Therapeutics, and member of the International Advisory Council for the Gout Education Society. The two explore the broad reach of gout across different demographics, discuss how gout presents differently, and considerations healthcare professionals should be aware of during treatment. Key Takeaways: Gout doesn’t discriminate by age, gender, background, or diet. Doctors should be aware that the signs of gout aren’t always as straightforward. Misdiagnosis is common, so it’s important to take a step back and recognize the subtle symptoms. Genetics play a meaningful, but complex, role. Family history is a significant risk factor, however, research points to polygenic and epigenetic factors than one single genetic mutation. Demographics matter, but not in the way most people think. While men typically develop gout in their 40s-50s, the prevalence is nearly equal in women post-menopause. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards is joined by Dr. Robert Keenan, Chief Medical Officer at Arthrosi Therapeutics, and member of the Gout Education Society's International Advisory Council. Today, Dr. Keenan and Dr. Edwards will discuss how gout affects different populations, the role of genetics and gender on gout, and how medical professionals can better serve diverse communities. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. I'm happy to be joined today by Dr. Robert Keenan, internationally recognized expert in the field of gout. He's also the Chief Medical Officer of Arthrosi Therapeutics, and I'm delighted to have us join in our conversation. Can you start off, Rob, by telling a little bit about what your interest in gout has been over the years and what kind of studies and research you've done? Dr. Robert KeenanYeah. Thanks for having me. I appreciate the opportunity to talk about my favorite medical topic or my favorite topic, probably in general, much to my wife's dismay, of gout. Yeah, so I got interested in gout back in medical school, quite honestly, and then my interest further developed in residency, then subsequently in fellowship. I had the opportunity at NYU to start a gout registry with the VA there, and that kind of really kicked off my clinical research interest. From there, I just continued it on as I transitioned to Duke University, and I started a gout clinic and kept up with the clinical research there as a principal investigator for a number of drug studies, as well as principal investigator for some epidemiological studies that were externally funded. So that's kind of how I kept the love of gout and the love of treatment of gout and taking care of this patient population over the last twenty-plus years now. Dr. Larry EdwardsYeah, it's an incredibly interesting disease with a crazy history to it. It certainly is a fun thing to study, and the nice thing is that it's essentially a curable disease if patients listen to the recommendations. We have good medications. We're getting better medications coming down the pipeline, so I think that there's a lot of hope for the future. Let's go ahead, Rob, and start off the discussion today, talking really about the demographics of gout, who gets gout. It's said that there's about 9 to 12 million adults in the United States that have gout, coming to about 4% of the population of adults. What else can you tell us about the demographics of this disease? Dr. Robert KeenanYeah. So I like to tell patients that gout doesn't discriminate. I mean, there's a lot of misnomer about. Oh, it's the over-indulgent rich person who eats too much, you know, meat and drinks too much alcohol, that gets you gout. But really, I mean, just pretty much gout can affect any ethnicity, any race across the spectrum. Of course, men are more likely to get gout earlier on, so you think about the typical gout patient as a man in his fifties, you know, late forties, early fifties when they first initially present with their first flare. But eventually, women do catch up with men post-menopausal. So once they reach menopause, the incidence and prevalence of gout in women starts to catch up with that of men. So by the time they're seventy-five, eighty, it's pretty much almost equal to that of men. Again, it can affect anybody. Now, typically, as far as who gets gout the most, so to speak, there was a recent study that was put out by Yokosi a couple of years ago. I guess it was twenty twenty-three years ago that showed that over the last couple of decades, the Asian population in the US, actually, their prevalence doubled from about 3.3% to about 6.6%. That was a higher increase and a higher rate of increase in prevalence compared to every other ethnic group, including whites and blacks and Hispanics. So I thought that was interesting. If you look at the black population in general, their prevalence of gout is also higher than that of whites. And you can think, “Well, maybe this is something genetic,” and it's probably not genetics, especially when people develop gout in their fifties and sixties. You know, you’ve got to think about a genetic component when they're developing gout in their late teens or twenties, for example. But it's not so much genes as it is just potentially lifestyle, other comorbid illnesses like chronic kidney disease or metabolic syndrome. If you look at that Yokosi study of the Asian population being doubled, you know, it wasn't double. It was actually lower than whites about thirty years ago. So, as with blacks, it could be just a lack of access to care. It could be not being started on urate-lowering therapy when they should. So that kind of pretty much dictates, and if they develop gout and have not started on anything to bring their uric acid down, then they're more likely to have gout longer, more flares, and more severe gout down the road. Dr. Larry EdwardsThere's been a lot of work on the genetics of it, and we can talk about that in a short while. I think other components you've mentioned are the gender, of course, with men predominant early on in the forties, fifties, and sixties, and women becoming much more susceptible to gout as they get into their seventies and eighties. The frequency of gout in that older population, seventy-five, eighty, is actually very high, 20%, 25% percent of the population of adults. Can you talk a little bit about age? You mentioned earlier on, Rob, that the image that most people have of gout is some portly old white guy sitting around drinking some alcoholic beverage or eating a large meal. We know that that's not the primary source of problems. Can you talk about the type of people that you see that would really say that that's not the problem, as far as women, as far as athletes getting it, people that don't drink, people that don't eat meat? All of those are in the spectrum. Dr. Robert KeenanYeah, exactly. So that's where potentially some of those genes kind of come into play in that patient population, especially whether it's women, and just post-menopausal, and especially if they have a strong family history, their father had gout, their grandfather had gout, their brothers have gout, there's a good chance they'll develop gout. A lot of times, in women, they'll present different than men. They won't necessarily present with a big, hot, painful red big toe. They'll present with it in their hands, for example, and it might not even flare like a typical gout flare. It might be a little more subtle. And I think that's important for women to recognize because, you know, I've had patients, women patients who came to me for joint pain in their hands, and, you know, they obviously had some osteoarthritis in their hands, and they came to me saying their pain's just getting worse, and they're having episodes where it's just worse some days than others. Sure enough, I say, "Well, this looks like it could be potentially gout." And, you know, one patient I can think of off the top of my head said, "I don't have gout. My husband has gout, but I don't have gout. There's no way I have gout. He eats too much," et cetera, et cetera. I said, "Well, I think you may have gout. Let's take some X-rays and see what we see, and then check uric acid and see what we see." And sure enough, she had gout on top of her osteoarthritis in her hands. So that patient population certainly is not gonna be necessarily typical in many ways, not only, you know, necessarily what they're eating or not eating,...

30. jan. 2026 - 17 min
episode The Two-Way Street: Gout’s Impact on Renal Function – and Vice Versa cover

The Two-Way Street: Gout’s Impact on Renal Function – and Vice Versa

Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Richard Johnson, board-certified nephrologist and member of the Board of Directors for the Gout Education Society. The two explore the connection between gout and kidney health through topics like uric acid regulation through the kidneys, treatment options, and considerations for medical professionals in charge of care should keep in mind. Key Takeaways: The kidneys play a central role in uric acid regulation. About two-thirds of uric acid is excreted by the kidneys, and one-third by the gut. When kidney function declines, uric acid retention occurs, increasing gout risk. Kidney disease and gout are closely linked to one another. Chronic kidney disease (CKD) is a major cause of gout because impaired kidney function leads to uric acid buildup. Conversely, high uric acid may contribute to CKD progression, creating a vicious cycle. In those with kidney disease, treatment can look a bit different. Notably, NSAIDs may not be an option due to their harmful impact on the kidneys. For those with kidney disease looking for pain relief from a gout flare, options like steroids should be considered. Also, historical dosing restrictions for allopurinol in CKD have led to undertreatment, but recent evidence supports gradual titration to higher doses when monitored. For medical professionals, it’s important to screen those with gout for kidney disease and vice versa. Medications known to raise uric acid should also be reviewed, namely, diuretics. Comorbidities should always be considered when treating gout. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards is joined by Dr. Richard Johnson, board-certified nephrologist, professor emeritus at the University of Colorado Anschutz Medical Campus, and board member of the Gout Education Society. Today, Dr. Johnson and Dr. Edwards will discuss the connection between gout and kidney health, how uric acid is regulated, and the challenges patients face when both conditions exist. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. I'm happy to be joined today by Dr. Richard Johnson, who's a board-certified nephrologist, an internationally recognized researcher, and a member of the board of directors of the Gout Education Society. Welcome to you today, Rick. What I'd like to do is ask you to just briefly here talk about your interest in gout, how that came about, gout and uric acid. Dr. Richard JohnsonYeah. Well, first off, thank you, Larry, for inviting me to be on this podcast. It's a real delight to see you again and to interact with the people who are interested in gout. I'm a kidney doctor, and gout is very common in kidney disease. And so, just by nature, I've seen many patients with gout. But what happened was, in my research, where I was investigating mechanisms of kidney disease and high blood pressure, I became interested in the role of uric acid in kidney disease and blood pressure. Over the years, I have studied this with National Institutes of Health (NIH) funding and other grants to try to understand if uric acid might have a biologic role in diseases, not just gout, but in diseases such as high blood pressure, chronic kidney disease, metabolic syndrome, and so forth. It's a controversial topic, but that's where I've spent much of my research career over the last twenty-plus years. Dr. Larry EdwardsYou've certainly been at the forefront of that area of investigation over that time period. Can I get you to just do a brief overview of the role the kidneys have in regulating uric acid? Dr. Richard JohnsonYes. It's a very important role for the kidney. Uric acid is a breakdown product of purines, which are nitrogen-containing substances that are in our cells, DNA, and other RNA. And just as we have to get rid of waste, when the purines break down, they form uric acid. In many animals, there's an enzyme that degrades uric acid, and so that's the main way you get rid of uric acid, you know, like most mammals do. But humans and some other species, like apes and also birds, and reptiles, lost this enzyme. And so we have to get rid of uric acid from our body a different way. We don't have the enzyme to degrade uric acid, and so we have to get rid of it typically through the urine. And about two-thirds of the uric acid we get rid of goes out through the kidneys into the urine. One-third is removed by the gut. So the gut, or intestines, especially the large intestines, have bacteria that degrade uric acid. There's some movement of uric acid in and out of the intestines, and about one-third of uric acid is removed by the gut. When people start developing kidney disease, they'll start to have some problems with excreting uric acid through the kidneys because with less kidney function, there's less filtering, and it's harder to get the uric acid out. And so the intestines increase their workload to remove uric acid a little bit in response to that. But it's usually not enough, and so uric acid starts to be retained in our blood. As the uric acid levels go up, we become at risk for gout and other complications associated with high uric acid. But when the kidneys are not working, the uric acid levels tend to go up. In people who start dialysis, for example, about half of them will have a uric acid level of greater than seven. It's very, very common to develop gout with kidney disease because you're retaining the uric acid. So, kidney disease is a major cause of gout because as you get worse kidney disease, your uric acid tends to go up, and as the uric acid levels get over seven, the risk increases for the uric acid to crystallize into joints and to cause gout. It's been known for a long time that you can develop gout because of your diet, you know, from eating foods very rich in purines. Beer and alcohol will generate uric acid. Sugar can generate uric acid. So you can raise your uric acid by diet, but the two other major risk factors are genetics, if you have a genetic predisposition to have gout, and the other is if you develop kidney disease, because as you develop kidney disease, you retain uric acid. So, kidney disease is very important in people with gout, and everybody with gout should have their kidney function tested. Dr. Larry EdwardsAnd genetic mutations in these transport systems, both in the gut and in the proximal part of the kidney, I think, are very important and have been researched extensively here for the past fifteen years. I have always been impressed over the last thirty, forty years that I've been looking at these things that uric acid was so tightly regulated by multiple transport systems in the kidney transport systems in the gut that you talked about. Why do you think uric acid has that much influence as far as the body is concerned? Dr. Richard JohnsonWell, you know, there is this problem where if the uric acid levels go up really high, and this is particularly seen in some animals that also lack this enzyme. So we lack this uricase enzyme that, if we had that enzyme, it would protect us if our uric acid levels go up. It would degrade the uric acid, and it wouldn't matter if you had kidney disease or not. But in some animals, especially reptiles and birds, for example, if their kidney function gets worse, they can retain very high levels of uric acid, where the crystals don't just form in the joints, but also in the kidneys and in the heart and throughout the body, and it's actually got the name visceral gout. It's fatal, basically. It's really massive crystallizations associated with aneurysms and severe high blood pressure. Visceral gout is a problem. Now, in humans, we rarely see visceral gout, but there are reports. I was on a paper that described a couple hundred cases of uric crystals forming outside of joints. And usually these are people with kidney disease, and the uric crystals just overwhelm. You can find them in the heart, in the blood vessels, in the kidneys, in the skin, in the eyes. And I've seen a few patients with this over the years, and it's really a horrible syndrome often associated with uric acid levels of fifteen or higher. So the kidneys, though, become so important for getting rid of uric acid. And it's controlled in the tubules. So what happens is after the blood is filtered in the filters of the kidneys, we have millions of filters called glomeruli. And then the urine runs down tubules until it gets into the ureter and then goes into the bladder. It's full of urine, and then you excrete it. But the urine is initially partially filtered. It's first filtered,...

10. dec. 2025 - 30 min
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
Rigtig god tjeneste med gode eksklusive podcasts og derudover et kæmpe udvalg af podcasts og lydbøger. Kan varmt anbefales, om ikke andet så udelukkende pga Dårligdommerne, Klovn podcast, Hakkedrengene og Han duo 😁 👍
Podimo er blevet uundværlig! Til lange bilture, hverdagen, rengøringen og i det hele taget, når man trænger til lidt adspredelse.

Vælg dit abonnement

Mest populære

Begrænset tilbud

Premium

20 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

2 måneder kun 19 kr.
Derefter 99 kr. / måned

Kom i gang

Premium Plus

100 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

Prøv gratis i 7 dage
Derefter 129 kr. / måned

Prøv gratis

Kun på Podimo

Populære lydbøger

Ofte stillede spørgsmål

Flere spørgsmål og svar
Kom i gang

2 måneder kun 19 kr. Derefter 99 kr. / måned. Opsig når som helst.